These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24418935)

  • 41. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P; Balkovec S; Solomon M; Ratjen F
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility study of propagation-based phase-contrast X-ray lung imaging on the Imaging and Medical beamline at the Australian Synchrotron.
    Murrie RP; Stevenson AW; Morgan KS; Fouras A; Paganin DM; Siu KK
    J Synchrotron Radiat; 2014 Mar; 21(Pt 2):430-45. PubMed ID: 24562566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The facilitating effect of hypertonic saline on resolution of airway inflammation in cystic fibrosis.
    Reeves EP; McElvaney NG
    Am J Respir Crit Care Med; 2012 Jan; 185(2):226-7. PubMed ID: 22351955
    [No Abstract]   [Full Text] [Related]  

  • 44. Methods for dynamic synchrotron X-ray respiratory imaging in live animals.
    Morgan KS; Parsons D; Cmielewski P; McCarron A; Gradl R; Farrow N; Siu K; Takeuchi A; Suzuki Y; Uesugi K; Uesugi M; Yagi N; Hall C; Klein M; Maksimenko A; Stevenson A; Hausermann D; Dierolf M; Pfeiffer F; Donnelley M
    J Synchrotron Radiat; 2020 Jan; 27(Pt 1):164-175. PubMed ID: 31868749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sodium channel blockers for cystic fibrosis.
    Burrows EF; Southern KW; Noone PG
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD005087. PubMed ID: 24715704
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sodium channel blockers for cystic fibrosis.
    Burrows EF; Southern KW; Noone PG
    Cochrane Database Syst Rev; 2012 Mar; (3):CD005087. PubMed ID: 22419304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
    Amin R; Subbarao P; Jabar A; Balkovec S; Jensen R; Kerrigan S; Gustafsson P; Ratjen F
    Thorax; 2010 May; 65(5):379-83. PubMed ID: 20435858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
    Elkins MR; Robinson M; Rose BR; Harbour C; Moriarty CP; Marks GB; Belousova EG; Xuan W; Bye PT;
    N Engl J Med; 2006 Jan; 354(3):229-40. PubMed ID: 16421364
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for airway surface dehydration as the initiating event in CF airway disease.
    Boucher RC
    J Intern Med; 2007 Jan; 261(1):5-16. PubMed ID: 17222164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mucociliary transport determined by in vivo microdialysis in the airways of normal and CF mice.
    Grubb BR; Jones JH; Boucher RC
    Am J Physiol Lung Cell Mol Physiol; 2004 Mar; 286(3):L588-95. PubMed ID: 14633516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Inhaled therapies for cystic fibrosis].
    Lahzami S; Nicod LP
    Rev Med Suisse; 2011 Nov; 7(318):2285-8. PubMed ID: 22400363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
    N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline.
    Subbarao P; Stanojevic S; Brown M; Jensen R; Rosenfeld M; Davis S; Brumback L; Gustafsson P; Ratjen F
    Am J Respir Crit Care Med; 2013 Aug; 188(4):456-60. PubMed ID: 23742699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nebulized hypertonic saline in noncystic fibrosis bronchiectasis: a comprehensive review.
    Máiz Carro L; Martínez-García MA
    Ther Adv Respir Dis; 2019; 13():1753466619866102. PubMed ID: 31390940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ENaC-mediated effects assessed by MRI in a rat model of hypertonic saline-induced lung hydration.
    Blé FX; Cannet C; Collingwood S; Danahay H; Beckmann N
    Br J Pharmacol; 2010 Jun; 160(4):1008-15. PubMed ID: 20590595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypertonic saline treatment of cystic fibrosis.
    Taylor LM; Kuhn RJ
    Ann Pharmacother; 2007 Mar; 41(3):481-4. PubMed ID: 17327291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Will Airway Gene Therapy for Cystic Fibrosis Improve Lung Function? New Imaging Technologies Can Help Us Find Out.
    Parsons D; Donnelley M
    Hum Gene Ther; 2020 Sep; 31(17-18):973-984. PubMed ID: 32718206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nebulized hypertonic saline triggers nervous system-mediated active liquid secretion in cystic fibrosis swine trachea.
    Luan X; Tam JS; Belev G; Jagadeeshan S; Murray B; Hassan N; Machen TE; Chapman LD; Ianowski JP
    Sci Rep; 2019 Jan; 9(1):540. PubMed ID: 30679487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypertonic saline for cystic fibrosis: worth its salt?
    Goralski JL; Donaldson SH
    Expert Rev Respir Med; 2014 Jun; 8(3):267-9. PubMed ID: 24666113
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term improvement of lung clearance index in patients with mild cystic fibrosis lung disease: Does hypertonic saline play a role?
    Ellemunter H; Eder J; Fuchs S; Gappa M; Steinkamp G
    J Cyst Fibros; 2016 Jan; 15(1):123-6. PubMed ID: 26190829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.